US Government Calls For Additional 200M Doses Of Pfizer-BioNTech COVID Shot

·1 min read
  • The U.S. government has purchased an additional 200 million doses of the Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) COVID-19 Vaccine.

  • The incremental doses will be delivered from October 2021 through April 2022.

  • The order of additional doses brings the companies' total number of doses to the U.S. government under its existing supply agreement to 500 million.

  • The companies expect to deliver 110 million of the additional doses by December 31, 2021, with the remaining 90 million doses delivered by April 30, 2022.

  • The U.S. government also can acquire the booster shots targeting potential variants and new formulations of the vaccine, if available and authorized.

  • Price Action: BNTX shares are up 1.18% at $284.21, while PFE shares are down 0.14% at $41.41 during the premarket session on the last check Friday.

  • Photo by x3 from Pixabay

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting